Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells.

Our data proves tumor-promoting role of MAGEA3 and provides the rationale to target MAGEA3 and/or its functional mediators like CCL2 for PCA, which may have a better impact in PCA therapy.